Texosome-based drug delivery system for cancer therapy: from past to present
Rising worldwide cancer incidence and resistance to current anti-cancer drugs necessitate the need for new pharmaceutical compounds and drug delivery system. Malfunction of the immune system, particularly in the tumor microenvironment, causes tumor growth and enhances tumor progression. Thus, cancer...
Main Authors: | Hamideh Mahmoodzadeh Hosseini, Raheleh Halabian, Mohsen Amin, Abbas Ali Imani Fooladi |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2015-09-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/867 |
Similar Items
-
Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice
by: Elaheh Gheybi, et al.
Published: (2018-01-01) -
The MEMIC is an ex vivo system to model the complexity of the tumor microenvironment
by: Libuše Janská, et al.
Published: (2021-08-01) -
BH3-mimetics: recent developments in cancer therapy
by: Paul A. Townsend, et al.
Published: (2021-11-01) -
Anticancer Activity of Urease Mimetic Cobalt (III) Complexes on A549-Lung Cancer Cells: Targeting the Acidic Microenvironment
by: Bhawna Uprety, et al.
Published: (2022-01-01) -
A New Approach for Glyco-Functionalization of Collagen-Based Biomaterials
by: Ines Figuereido, et al.
Published: (2019-04-01)